Efficacy and safety of fourth-generation CD19 CAR-T expressing IL7 and CCL19 along with PD-1 monoclonal antibody for relapsed or refractory large B-cell lymphoma

被引：0
|
作者：
俞腾
机构：
[1] Med Coll
[2] Zhejiang Univ
[3] Dept Hematol
[4] 2nd Affil Hosp
来源：
China Medical Abstracts(Internal Medicine) | 2024年 / 41卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R733.1 [网状内皮系统肿瘤];
学科分类号：
摘要：
Objective To explore the efficacy and safety of fourthgeneration chimeric antigen receptor T-cells (CAR-T),which express interleukin 7 (IL7) and chemokine C-C motif ligand 19 (CCL19) and target CD19,in relapsed or refractory large B-cell lymphoma.Methods Our center applied autologous 7×19 CAR-T combined with tirelizumab to treat 11 patients with relapsed or refractory large B-cell lymphoma.The efficacy and adverse effects were explored.
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [21] Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
    Yang, Tingting
    Dong, Yetian
    Zhang, Mingming
    Feng, Jingjing
    Fu, Shan
    Xiao, Pingnan
    Hong, Ruimin
    Xu, Huijun
    Cui, Jiazhen
    Huang, Simao
    Wei, Guoqing
    Kong, Delin
    Geng, Jia
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [22] Updated Clinical Progress of IL-10 expressing CD19 CAR-T Cells for Treatment of Relapsed or Refractory B-Cell Hematological Malignancies at Tiny Doses
    Guo, Yugang
    Xu, Qianwen
    Xue, Lei
    Chen, Erlin
    Zhang, Xuhan
    Liu, Chonglin
    Gao, Min
    Li, Youjia
    Ren, Jingjing
    Sathiyanadan, Karthik
    Tang, Li
    Wang, Xingbing
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S593 - S594
  • [23] Efficacy and Safety of CD19-Targeted CAR-T Cell Therapy for Refractory/Relapsed B-Cell Lymphoma: A Single Center of Real World Data
    Huang, Jing
    Fei, Jia
    Ou, Ruiming
    Liu, Zhi
    Zheng, Liling
    Zhu, Yangmin
    Shen, Huijuan
    Du, Yuanyuan
    Zhou, Qinjun
    Chen, Jiali
    Zhou, Changhua
    Yan, Rongrong
    Wang, Jiale
    Liu, Shuang
    Zhang, Qing
    BLOOD, 2021, 138
  • [24] Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in China
    Ying, Zhitao
    Yang, Haiyan
    Guo, Ye
    Li, Wenyu
    Zou, Dehui
    Zhou, Daobin
    Wang, Zhao
    Zhang, Mingzhi
    Wu, Jianqiu
    Liu, Hui
    Zhang, Pian
    Yang, Su
    Zhou, Zisong
    Zheng, Hongxia
    Song, Yuqin
    Zhu, Jun
    CANCER MEDICINE, 2021, 10 (03): : 999 - 1011
  • [25] CD28-COSTIMULATED CD19 CAR T CELLS FOR PEDIATRIC RELAPSED AND REFRACTORY MATURE B-CELL LYMPHOMA
    Jacoby, Elad
    Adam, Etai
    Abramovich, Alon
    Shapira, Adi
    Hutt, Daphna
    Itzhaki, Orit
    Bielorai, Bella
    Toren, Amos
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 563 - 564
  • [26] CAR-T Therapy for the Treatment of Relapsed/Refractory CD19 Positive Large B Cell Lymphoma: Canadian Real-World Evidence
    Tan, Xiu Xia Sherry
    Maltez, Melissa
    Mallick, Ranjeeta
    Hamelin, Linda
    McDiarmid, Sheryl
    Kennah, Michael
    Atkins, Harold
    Kekre, Natasha K.
    BLOOD, 2023, 142
  • [27] Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia
    Zhou, Qianyi
    An, Yuxin
    Zhang, Xiaomei
    Xiao, Xia
    Bai, Xue
    Liu, Pengjiang
    Pu, Yedi
    Meng, Juanxia
    Zhu, Haibo
    Lyu, Cuicui
    Zhang, Huan
    Zhang, Yu
    Xie, Tianle
    Meng, Haotian
    Lyu, Hairong
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [28] CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study
    Wei, Guoqing
    Zhang, Yanlei
    Zhao, Houli
    Wang, Yiyun
    Liu, Yandan
    Liang, Bin
    Wang, Xiujian
    Xu, Huijun
    Cui, Jiazhen
    Wu, Wenjun
    Zhao, Kui
    Nagler, Arnon
    Chang, Alex H.
    Hu, Yongxian
    Huang, He
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (09) : 1061 - 1070
  • [29] Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma
    Eugenio Galli
    Federica Sorà
    Stefan Hohaus
    Silvia Bellesi
    Francesco Autore
    Elisabetta Metafuni
    Idanna Innocenti
    John Marra
    Alberto Fresa
    Maria Assunta Limongiello
    Sabrina Giammarco
    Lucia Leccisotti
    Andrea Guarneri
    Patrizia Chiusolo
    Luca Laurenti
    Luciana Teofili
    Nicola Piccirillo
    Andrea Bacigalupo
    Simona Sica
    Bone Marrow Transplantation, 2022, 57 : 837 - 839
  • [30] Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma
    Galli, Eugenio
    Sora, Federica
    Hohaus, Stefan
    Bellesi, Silvia
    Autore, Francesco
    Metafuni, Elisabetta
    Innocenti, Idanna
    Marra, John
    Fresa, Alberto
    Limongiello, Maria Assunta
    Giammarco, Sabrina
    Leccisotti, Lucia
    Guarneri, Andrea
    Chiusolo, Patrizia
    Laurenti, Luca
    Teofili, Luciana
    Piccirillo, Nicola
    Bacigalupo, Andrea
    Sica, Simona
    BONE MARROW TRANSPLANTATION, 2022, 57 (05) : 837 - 839
12345